To Examine the Effect of Horizant (Gabapentin Enacarbil) in Primary Restless Legs Syndrome (RLS) Patients Who Are on Dopaminergic Agents and Exhibiting Augmentation
Phase of Trial: Phase IV
Latest Information Update: 17 Feb 2017
At a glance
- Drugs Gabapentin enacarbil (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- 13 Feb 2017 Planned number of patients changed from 20 to 50.
- 09 Sep 2016 Status changed from not yet recruiting to recruiting.
- 09 Jan 2016 New trial record